Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial)
dc.contributor.author | Chew, Derek Peng | |
dc.contributor.author | Lincoff, A Michael | |
dc.contributor.author | Gurm, Hitinder | |
dc.contributor.author | Wolski, Katherine | |
dc.contributor.author | Cohen, David J | |
dc.contributor.author | Henry, Tim | |
dc.contributor.author | Feit, Frederick | |
dc.contributor.author | Topol, Eric J | |
dc.date.accessioned | 2010-07-27T06:03:28Z | |
dc.date.available | 2010-07-27T06:03:28Z | |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | Chew, D.P., Lincoff, A.M., Gurm, H., Wolski, K., Cohen, D.J., Henry, T., Feit, F., & Topol, E.J., 2005. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial). American Journal of Cardiology, 95(5), 581-585. | en |
dc.identifier.issn | 0002-9149 | en_US |
dc.identifier.uri | http://hdl.handle.net/2328/9998 | |
dc.title | Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial) | en_US |
dc.type | Article | en_US |
dc.identifier.rmid | 2005100965 | en_US |
dc.identifier.doi | https://doi.org/10.1016/j.amjcard.2004.11.003 | en |
dc.subject.forgroup | 1102 Cardiovascular Medicine and Haematology | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
1102 - Cardiovascular Medicine and Haematology
Flinders' staff research in Cardiovascular Medicine and Haematology, reportable as part of ERA, 2001- -
1102 - Cardiovascular Medicine and Haematology
Flinders' research in Cardiovascular Medicine and Haematology, as reported for ERA 2012.